Published in Inflammation on April 01, 1997
Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation (1998) 0.93
Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol (1994) 3.03
Successful treatment of Behçet disease with pentoxifylline. Ann Intern Med (1996) 2.81
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs (1987) 2.54
Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol (1987) 1.97
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol (1985) 1.96
Enhancement of neutrophils function as a result of prior exposure to chemotactic factor. J Clin Invest (1980) 1.64
Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today (1995) 1.51
Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils. J Cell Biol (1990) 1.48
Gating by cyclic AMP: expanded role for an old signaling pathway. Science (1996) 1.46
FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase. J Clin Invest (1994) 1.45
Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J Immunol (1991) 1.43
Priming of the respiratory burst of bone marrow-derived macrophages is associated with an increase in protein kinase C content. J Immunol (1992) 1.42
Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest (1986) 1.41
Amelioration of reperfusion injury by pentoxifylline after lung transplantation. The Université Paris-Sud Lung Transplant Group. J Heart Lung Transplant (1995) 1.40
The superoxide-forming enzymatic system of phagocytes. Free Radic Biol Med (1988) 1.37
Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol (1986) 1.31
Enhancement of human neutrophil bactericidal activity by chemotactic factors. Infect Immun (1979) 1.30
Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun (1994) 1.13
Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci U S A (1994) 1.13
Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils. Biochim Biophys Acta (1986) 1.13
Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther (1985) 1.12
Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol (1991) 1.11
ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis (1988) 1.10
Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2. J Clin Invest (1994) 1.06
Role of stimulated neutrophils from patients with systemic lupus erythematosus in tissue injury, with special reference to serum factors and increased active oxygen species generated by neutrophils. Inflammation (1985) 1.05
Human neutrophil migration into skin chambers is associated with production of NAP-1/IL8 and C5a. Eur J Haematol (1991) 1.00
Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst. J Biol Chem (1987) 0.99
Neutrophil priming by lipopolysaccharide involves heterogeneity in calcium-mediated signal transduction. Studies using fluo-3 and flow cytometry. J Immunol (1993) 0.98
Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol (1993) 0.95
Comparative superoxide-generating system of granulocytes from blood and peritoneal exudates. Infect Immun (1984) 0.90
Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma (1990) 0.89
Dual mechanisms in priming of the chemoattractant-induced respiratory burst in human granulocytes. A Ca2+-dependent and a Ca2+-independent route. J Immunol (1989) 0.88
Exudate polymorphonuclear leukocytes isolated from skin chambers are primed for enhanced response to subsequent stimulation with chemoattractant f-Met-Leu-Phe and C3-opsonized yeast particles. Inflammation (1988) 0.88
Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions. Infect Immun (1994) 0.87
Activation of neutrophils by cachectin/tumor necrosis factor: priming of N-formyl-methionyl-leucyl-phenylalanine-induced oxidative responsiveness via receptor mobilization without degranulation. J Leukoc Biol (1990) 0.86
Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol (1996) 0.86
Simultaneous assay for oxidative metabolism and adhesion of human neutrophils: evidence for correlations and dissociations of the two responses. J Leukoc Biol (1992) 0.86
Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha. J Med Chem (1996) 0.85
Bacterial lipopolysaccharide enhances polymorphonuclear leukocyte function independent of changes in intracellular calcium. Inflammation (1990) 0.85
Radioimmunoassay of cyclic AMP can provide a highly sensitive assay for adenylate cyclase, even at very high ATP concentrations. Anal Biochem (1985) 0.83
Neutrophil activation after burn injury: contributions of the classic complement pathway and of endotoxin. Surgery (1987) 0.83
Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen Pharmacol (1994) 0.83
Cyclic AMP-elevating agents down-regulate the oxidative burst induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) in adherent neutrophils. Clin Exp Immunol (1995) 0.81
Priming of human neutrophils with N-formyl-methionyl-leucyl-phenylalanine by a calcium-independent, pertussis toxin-insensitive pathway. Blood (1989) 0.81
Pentoxifylline at clinically achievable levels inhibits FMLP-induced neutrophil responses, but not priming, upregulation of cell-adhesion molecules, or migration induced by GM-CSF. Eur J Haematol (1993) 0.79
Adenosine modulation of tumor necrosis factor-alpha-induced neutrophil activation. Biochem Pharmacol (1995) 0.78
Effect of pentoxifylline on changes in neutrophil sequestration and emigration in the lungs. Am J Physiol (1995) 0.78
Priming of human polymorphonuclear leukocytes with granulocyte-macrophage colony-stimulating factor involves protein kinase C rather than enhanced calcium mobilisation. Eur J Biochem (1992) 0.78
Phospholipase A2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst. J Immunol (1993) 0.78
Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock (1994) 0.78
In vivo modulation of human neutrophil function by pentoxifylline in patients with septic syndrome. Shock (1995) 0.77
Role of protein kinase C in neutrophil survival enhanced by granulocyte colony-stimulating factor. Exp Hematol (1993) 0.76
Factor-specific changes in oxidative burst response of human neutrophils in skin-window exudates. Inflammation (1993) 0.76
Receptor-independent mechanisms are involved in the priming of neutrophil's oxidase by vasoactive intestinal peptide. Regul Pept (1994) 0.76
Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established. Arch Surg (1994) 0.76
Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation. Biochem Pharmacol (1994) 0.76
Differential regulation of early phase and late phase responses in human neutrophils by cAMP. Biochem Pharmacol (1993) 0.76
Pentoxifylline inhibits FMLP-induced macromolecular leakage. Am J Physiol (1995) 0.76
Neutrophil migration in health and disease. Semin Hematol (1975) 0.76
Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis (2007) 1.86
Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. Lupus (1998) 1.68
Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy (2002) 1.51
Chikungunya outbreak--remember the arthropathy. Rheumatology (Oxford) (2006) 1.45
A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem (1994) 1.29
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
A new case of reactive arthritis after hepatitis B vaccination. Clin Exp Rheumatol (1993) 1.17
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (1988) 1.10
Cryoglobulinaemia and hepatitis C virus (HCV) infection. Clin Exp Rheumatol (1991) 1.08
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
Molecular basis of macrophage activation. Expression of the low potential cytochrome b and its reduction upon cell stimulation in activated macrophages. J Immunol (1986) 1.04
The measurement of superoxide anion production by granulocytes In whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity. Eur J Clin Invest (1983) 1.03
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest (1999) 1.00
The cytochrome b and flavin content and properties of the O2- -forming NADPH oxidase solubilized from activated neutrophils. Biochim Biophys Acta (1983) 1.00
Ultrasound differentiation of two types of de Quervain's disease: the role of retinaculum. Ann Rheum Dis (2009) 1.00
Spinal subarachnoid bleeding of unknown etiology. Case reports. J Neurosurg Sci (2001) 0.99
Spinal dermoid cysts originating intracranial fat drops causing obstructive hydrocephalus: case reports. Surg Neurol (1995) 0.99
Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study. Clin Rheumatol (2000) 0.97
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med (1999) 0.96
Studies on the NADPH oxidase of phagocytes. Production of a monoclonal antibody which blocks the enzymatic activity of pig neutrophil NADPH oxidase. J Biol Chem (1989) 0.96
Tapia's syndrome caused by a neurofibroma of the hypoglossal and vagus nerves: case report. J Neurosurg (1980) 0.95
[Liver involvement in systemic lupus erythematosus]. Recenti Prog Med (1993) 0.95
Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) (2007) 0.95
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum (2010) 0.94
Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin Exp Rheumatol (1993) 0.93
Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation (1998) 0.93
The generation of hydroxyl radicals following superoxide production by neutrophil NADPH oxidase. FEBS Lett (1982) 0.93
A microplate-based colorimetric assay of the total peroxyl radical trapping capability of human plasma. Anal Biochem (1999) 0.92
Partial purification of the superoxide-generating system of macrophages. Possible association of the NADPH oxidase activity with a low-potential (-247 mV) cytochrome b. Biochim Biophys Acta (1985) 0.91
Changes in several neutrophil functions in basketball players before, during and after the sports season. Int J Sports Med (1995) 0.91
The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol (1998) 0.91
Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement. Sarcoidosis Vasc Diffuse Lung Dis (2011) 0.90
Three clinical reports of Kikuchi's lymphadenitis combined with systemic lupus erythematosus. Clin Rheumatol (1996) 0.90
T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol (1997) 0.90
C3 nephritic factor and SLE: report of four cases and review of the literature. QJM (1994) 0.90
Studies on stimulus-response coupling in human neutrophils. I. Role of monovalent cations in the respiratory and secretory response to N-formylmethionylleucylphenylalanine. Biochim Biophys Acta (1983) 0.90
Anticentromere antibody--clinical associations. A study of 44 patients. Rheumatol Int (1995) 0.89
The NADPH oxidase of guinea pig polymorphonuclear leucocytes. Properties of the deoxycholate extracted enzyme. Mol Cell Biochem (1983) 0.89
Extracranial posterior inferior cerebellar artery aneurysm causing isolated intraventricular hemorrhage: a case report. Neurosurgery (1988) 0.89
Pseudoseptic arthritis in a patient with Behçet's disease. Clin Exp Rheumatol (2006) 0.88
Spinal meningeal melanocytoma. Case report and analysis of diagnostic criteria. Neurosurg Rev (1996) 0.88
Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients. Allergy (2002) 0.88
Middle ear mechanics in subjects with rheumatoid arthritis. Audiology (1997) 0.87
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease. Int J Immunopathol Pharmacol (2009) 0.86
Composition of partially purified NADPH oxidase from pig neutrophils. Biochem J (1984) 0.86
Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy (1991) 0.86
Intraventricular pneumocephalus after posterior fossa and CSF shunting surgery. Case report. J Neurosurg Sci (1994) 0.86
Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol (1996) 0.86
Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen. Pharmacol Res (1995) 0.86
Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis. Scand J Rheumatol (2006) 0.86
Neutrophil migration, oxidative metabolism, and adhesion in elderly and young subjects. Inflammation (1996) 0.86
The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production. Thromb Haemost (1996) 0.85
Sulfasalazine-induced immune thrombocytopenia. Postgrad Med J (2007) 0.84
Effect of acute exercise on some haematological parameters and neutrophil functions in active and inactive subjects. Eur J Appl Physiol Occup Physiol (1995) 0.84
Intensity and kinetics of the respiratory burst of human neutrophils in relation to receptor occupancy and rate of occupation by formylmethionylleucylphenylalanine. Biochim Biophys Acta (1985) 0.84
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis (2008) 0.84
Fatty acids and antioxidant micronutrients in psoriatic arthritis. J Rheumatol (1995) 0.84
Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features. Rheumatology (Oxford) (2005) 0.84
A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol (2002) 0.83
The enzyme responsible for the respiratory burst in elicited guinea pig peritoneal macrophages. J Pathol (1982) 0.83
Enzymatic basis of the respiratory burst of guinea pig resident peritoneal macrophages. J Reticuloendothel Soc (1981) 0.83
Dual effects of a homeopathic mineral complex on carrageenan-induced oedema in rats. Br Homeopath J (1999) 0.83
Mechanism of production of toxic oxygen radicals by granulocytes and macrophages and their function in the inflammatory process. Pathol Res Pract (1985) 0.83
A 1.1-kb duplication in the p67-phox gene causes chronic granulomatous disease. Hum Genet (2001) 0.83
Interrelationship between oxygen consumption, superoxide anion and hydrogen peroxide formation in phagocytosing guinea pig polymorphonuclear leucocytes. Mol Cell Biochem (1979) 0.83
Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis (2006) 0.83
NADPH oxidase of neutrophils forms superoxide anion but does not reduce cytochrome c and dichlorophenolindophenol. FEBS Lett (1984) 0.83